TY  - GEN
AU  - Gogas,Helen J
AU  - Flaherty,Keith T
AU  - Dummer,Reinhard
AU  - Ascierto,Paolo A
AU  - Arance,Ana
AU  - Mandala,Mario
AU  - Liszkay,Gabriella
AU  - Garbe,Claus
AU  - Schadendorf,Dirk
AU  - Krajsova,Ivana
AU  - Gutzmer,Ralf
AU  - Sileni,Vanna Chiarion
AU  - Dutriaux,Caroline
AU  - de Groot,Jan Willem B
AU  - Yamazaki,Naoya
AU  - Loquai,Carmen
AU  - Gollerkeri,Ashwin
AU  - Pickard,Michael D
AU  - Robert,Caroline
TI  - Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management
SN  - 1879-0852
PY  - 2020///0608
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Benzimidazoles
KW  - Carbamates
KW  - Fatigue
KW  - chemically induced
KW  - Female
KW  - Humans
KW  - Incidence
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Mitogen-Activated Protein Kinases
KW  - antagonists & inhibitors
KW  - Mutation
KW  - Nausea
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins B-raf
KW  - Skin Neoplasms
KW  - Sulfonamides
KW  - Vemurafenib
KW  - Vomiting
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ejca.2019.07.016
ER  -